Atom Investors’s Tectonic Therapeutic TECX Stock Holding History

Atom Investors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,206	Closed	-$599K	–	498
2020 Q1	$599K	Buy	+3,206	New	+$755K	0.05%	190

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Atom Investors's TECX Position: Q2 2020 in Review

Atom Investors sold out of Tectonic Therapeutic (TECX) in Q2 2020, closing a stake of 3,206 shares — an estimated $599K sold.

Atom Investors first reported a position in TECX in Q1 2020 and held it in 1 quarter. The position peaked at $599K in Q1 2020. 98 funds tracked by Wall St. Rank hold TECX as of Q2 2020.

Atom Investors reported no remaining Tectonic Therapeutic position as of Q2 2020 after selling out during the quarter.
Atom Investors sold 3,206 Tectonic Therapeutic shares in Q2 2020, an estimated $599K.
Atom Investors first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 1 quarter.
Atom Investors's Tectonic Therapeutic position peaked at $599K in Q1 2020.
98 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2020.

Based on Atom Investors's 13F filing for Q2 2020, filed 14 Aug 2020.